Elsevier announces winners of the 2017 Reaxys PhD Prize

Three young chemistry researchers recognized for their innovative and original research

Shanghai, October 25, 2017

Elsevier, the information analytics business specializing in science and health, announced the three winners of the 2017 Reaxys PhD Prize at its annual Symposium held in Shanghai, China.

Celebrating top research by leading young chemists across the globe, the Reaxys PhD Prize recognizes innovative and original research in chemistry, with an emphasis on synthesis. Since its inception eight years ago, the Reaxys PhD Prize received more than 3,500 submissions from over 50 countries.

The 2017 Reaxys PhD Prize winners are:

  • Joshua Barham from the Murphy group, University of Strathclyde
    Presentation title: Contra-Thermodynamic Hydrogen Atom Transfer: The Selective N-CH3 Functionalisation of Trialkylamines
  • Moritz Malischewski from the Seppelt group, Freie University of Berlin
    Presentation title: Organometallic Chemistry in Superacids
  • Changchun Yuan from the Liu group, Sichuan University
    Presentation title: Total Syntheses of Bolivianine, Sarcandrolide J and Shizukaol D: Inspired but not Limited by Nature

The three winners each received a check of USD $2,000 and joined a private network of 350+ talented chemists from around the world, the Reaxys Prize Club.

“I am very happy. The competition was very intense: there were so many applications and the level of the finalists’ research was great. Being at the Reaxys PhD Prize Symposium sharing my work is a great opportunity to meet colleagues and make friends,” said Moritz Malischewski, Freie University of Berlin, one of the three winners.”

“The quality of the oral presentations was great. All 10 were very good. As ever the decision process was not easy we had to consider the reviewer comments, and our review of the presentations. But in the end, all of the review committee agreed, and I think we have three outstanding winners,” said Prof Henry N. C. Wong, Chinese University of Hong Kong.

The winners were selected from a group of 10 finalists, who were challenged to present the key aspects of their research in a crisp yet critical manner at the Symposium. The presentations were judged by members of the Reaxys Advisory Board and the Reaxys PhD Prize Review Board.

Read more about the Reaxys PhD Prize, this year’s 45 finalists, shortlisted candidates and the Symposium.


About Reaxys
Reaxys empowers chemistry research and development by providing structure, property and reaction data, experimental procedures and literature. It is designed to support early drug discovery, education, material selection and synthesis planning; its capabilities include data export and integration to enable harmonized analysis of in-house and external data. Reaxys improves R&D productivity by delivering the facts the way chemists need them. www.elsevier.com/reaxys

Reaxys is a trade mark of RELX Intellectual Properties SA, used under license.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Media Contact
Christopher Capot
Global Communications, Elsevier
+1 917 704 5174